Lithium

Lithium

SCHEMBL2182527

CCNC(=O)Nc1nc2c(F)c(-c3cccc(NC(=O)CCC(=O)O)c3)cc(-c3ccccn3)c2s1.[Li]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.43
▸ ABL1 P00519 5/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ GFER P55789 1/20 0.38
▸ CYSLTR2 Q9NS75 1/20 0.38
▸ CYSLTR1 Q9Y271 1/20 0.38
▸ LIMK1 P53667 1/20 0.38
▸ LIMK2 P53671 1/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ GLA P06280 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ CDK8 P49336 1/20 0.36
▸ PTPN1 P18031 1/20 0.36
▸ PTPRA P18433 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2182513 0.98 ALDH1A1 (0.43) ALDH1A1ABL1MEN1KMT2AGFER
Lithium Ion SCHEMBL2182517 0.92 ABL1 (0.39) ALDH1A1ABL1KMT2ALIMK1LIMK2
Lithium SCHEMBL1844267 0.86 MAPK1 (0.45) ABL1SMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL1843136 0.85 MAPK1 (0.46) ABL1SMN1; SMN2NPC1RAB9AMAPK1
SCHEMBL1844259 0.85 MAPK1 (0.45) ABL1SMN1; SMN2NPC1RAB9AMAPK1
Lithium SCHEMBL1842713 0.84 ABL1 (0.41) ABL1SMN1; SMN2NPC1RAB9A
SCHEMBL4540026 0.83 ABL1 (0.41) ABL1SMN1; SMN2NPC1RAB9A
SCHEMBL1842700 0.83 ABL1 (0.41) ABL1SMN1; SMN2NPC1RAB9A
SCHEMBL1842971 0.82 ABL1 (0.43) ABL1SMN1; SMN2NPC1RAB9A
Lithium SCHEMBL1843160 0.82 ABL1 (0.43) ABL1GFERSMN1; SMN2KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166088-A1 BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2011-07-07 — — US claimed
US-20110166088-A1 BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2011-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166088-A1 BENZOTHIAZOLES AND AZA-ANALOGUES THEREOF USE AS ANTIBACTERIAL AGENTS TOP2B, TOP1, POLI ALDH1A1 2009/4885ABL1 1206/4885MEN1 4372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback